Date,Title,Link,Status,Source
"""Nov 28, 2017""","""Alexion (ALXN) Down 14.6% Since Earnings Report: Can It\u00a0Rebound?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/alexion-alxn-down-146-since-earnings-report-can-it-rebound-cm882955&cid=52779689520600&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNGWHGluqevqzQ_fEzzMJFwbJeqc_g""",1,"""Nasdaq"""
"""5 hours ago""","""TheStreet Downgrades Alexion Pharmaceuticals (ALXN) to\u00a0C+""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/30/thestreet-downgrades-alexion-pharmaceuticals-inc-alxn-to-c.html&cid=52779695972763&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNEdLfuSm36c2IVDcgZR2SR5c1tJoA""",Not Reachable,"""The Ledger Gazette"""
"""Nov 7, 2017""","""The Clear-Cut Reason Alexion Pharmaceuticals Tanked 15% in\u00a0October""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.fool.com/investing/2017/11/07/the-clear-cut-reason-alexion-pharmaceuticals-tanke.aspx&cid=52779663573752&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNHDvUEFzUkr2tIjbBMlxakLHMKvZg""",2,"""Motley Fool"""
"""13 hours ago""","""Alexion Pharmaceuticals, Inc. (ALXN) \u2013 Short Term Technical\u00a0look""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stocksgallery.com/2017/11/29/alexion-pharmaceuticals-inc-alxn-short-term-technical-look/&cid=52779693379498&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNG7pZiL63QHuxsqrWp59LeVHriAuQ""",3,"""Stocks Gallery"""
"""11 hours ago""","""Technical Secrets: Alexion Pharmaceuticals, Inc. (NASDAQ:\u00a0ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.hotstockspoint.com/2017/11/technical-secrets-alexion-pharmaceuticals-inc-nasdaq-alxn/&cid=52779696367300&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNHZpN7Y8p_Vd2yGORwgZjoUwqVXpw""",4,"""Hot Stocks Point"""
"""Nov 15, 2017""","""3 Big Stock Charts for Wednesday: Alexion Pharmaceuticals, Inc., Alliance Data\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://investorplace.com/2017/11/3-big-stock-charts-for-wednesday-alexion-pharmaceuticals-inc-alxn-alliance-data-systems-corporation-ads-and-snap-on-incorporated-sna/&cid=52779674379717&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNGjgCRRQhXrDuZr7wKTcguynz-k7Q""",5,"""Investorplace.com"""
"""Nov 22, 2017""","""Revenue Approximations Analysis: Henry Schein, Inc. (HSIC), Alexion\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/22/revenue-approximations-analysis-henry-schein-inc-hsic-alexion-pharmaceuticals-inc-alxn/&cid=52779684575136&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNHyXyZEp2w1If0U4bmTXSi0CHD-6w""",6,"""StockNewsJournal"""
"""14 hours ago""","""Tracking Analyst Views on Shares of Alexion Pharmaceuticals, Inc.\u00a0(NASDAQ:ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://thestocktalker.com/tracking-analyst-views-on-shares-of-alexion-pharmaceuticals-inc-nasdaqalxn/&cid=52779695468544&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNHQF0v0beICD7XTuyGaqz3RDBX1rg""",7,"""Stock Talker"""
"""Oct 31, 2017""","""Alexion Pharmaceuticals Inc. (ALXN) Dips 6.38% for October\u00a031""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.equities.com/news/alexion-pharmaceuticals-inc-alxn-dips-6-38-for-october-31&cid=52779657715616&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNEJRP5H0Uhjh4w09sXUqNTj3yj0EQ""",Not Reachable,"""Equities.com"""
"""Oct 30, 2017""","""Alexion to Present at the Citi 2017 Global Healthcare\u00a0Conference""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.businesswire.com/news/home/20171127005169/en/Alexion-Present-Citi-2017-Global-Healthcare-Conference&cid=0&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNEA09GuMvWd9pj5xcW4RSSi5ssSvQ""",8,"""Business Wire (press release)"""
"""Nov 7, 2017""","""Weak Sales Growth Drop Alexion Pharmaceuticals (ALXN) to\u00a0Sell""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://investorplace.com/2017/11/weak-sales-growth-drop-alexion-pharmaceuticals-alxn-to-sell/&cid=52779665675398&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNG2NvQKWbgl1P1wkzs5KtCsiICzHg""",9,"""Investorplace.com"""
"""17 hours ago""","""An easy way to pick winning stocks: Alexion Pharmaceuticals, Inc. (ALXN\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://usacommercedaily.com/2017/11/29/an-easy-way-to-pick-winning-stocks-alexion-pharmaceuticals-inc-alxn-prologis-inc-pld/&cid=52779696316453&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNFcG5hYUEVPRaWSv43JEmEzJ_yDgg""",10,"""USA Commerce Daily"""
"""Nov 28, 2017""","""Hot Stocks Among Investors: SLM Corporation (SLM), Alexion Pharmaceuticals\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://postanalyst.com/2017/11/28/hot-stocks-among-investors-slm-corporation-slm-alexion-pharmaceuticals-inc-alxn/&cid=52779694714204&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNFrElZi_O0w7JH3FuR7tHS7o5eDrQ""",11,"""Post Analyst"""
"""Nov 3, 2017""","""Alexion Pharmaceuticals, Inc. (ALXN): What's the\u00a0Story?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/03/alexion-pharmaceuticals-inc-alxn-whats-the-story-3/&cid=52779660205943&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNEv_h9M3j6G4Quuqvb7Q6wmTY_3aw""",12,"""StockNewsJournal"""
"""Nov 24, 2017""","""Why Investors remained buoyant on: Omega Healthcare Investors, Inc. (OHI\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/24/why-investors-remained-buoyant-on-omega-healthcare-investors-inc-ohi-alexion-pharmaceuticals-inc-alxn/&cid=52779684533288&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNHJzvVqtrst2e-IsUAPEgEj-UmXHw""",13,"""StockNewsJournal"""
"""Nov 24, 2017""","""Alexion Pharmaceuticals, Inc. (ALXN) Shares Sold by Gabelli Funds\u00a0LLC""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/24/gabelli-funds-llc-sells-9800-shares-of-alexion-pharmaceuticals-inc-alxn.html&cid=52779684988855&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNGxmzg1jroN8ACfSmJz5LTrSxS4DQ""",Not Reachable,"""The Ledger Gazette"""
"""Nov 27, 2017""","""A Side-by-side Analysis of Alexion Pharmaceuticals, Inc. (ALXN) and Vertex\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://economicsandmoney.com/2017/11/27/a-side-by-side-analysis-of-alexion-pharmaceuticals-inc-alxn-and-vertex-pharmaceuticals-incorporated-vrtx/&cid=52779690547485&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNHhXSw6BNLllRAsQPQHgdNpyXpTDQ""",14,"""Economic News"""
"""9 hours ago""","""Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) \u2013 Important Factors to Analyse A\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://nasdaqjournal.com/index.php/2017/11/29/alexion-pharmaceuticals-inc-nasdaqalxn-important-factors-to-analyse-a-good-investment/&cid=52779696379998&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNEp_FOhQXg0vxAmkG9ctDG8lmyHCw""",15,"""Nasdaq Journal (press release)"""
"""Nov 16, 2017""","""Today's Brokerage Rating: Alexion Pharmaceuticals, Inc. (ALXN), Advance Auto\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stocknewsjournal.com/2017/11/16/todays-brokerage-rating-alexion-pharmaceuticals-inc-alxn-advance-auto-parts-inc-aap/&cid=52779677969966&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNFLEGkzbEzojHM4hItGVU9XsUgP_Q""",16,"""StockNewsJournal"""
"""17 hours ago""","""Notable Stocks Intraday Alert: Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/29/notable-stocks-intraday-alert-alexion-pharmaceuticals-inc-nasdaq-alxn-g-iii-apparel-group-ltd-nasdaq-giii-mitsubishi-ufj-financial-group-inc-nyse-mtu-energy-transfer-equity-l-p/&cid=52779690486367&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNF5Crm_fe1w-yjU7rtlNpkZnmL8uA""",17,"""Stocks In The News (press release)"""
"""16 hours ago""","""Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN) Technicals In The\u00a0Spotlight""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://finnewsweek.com/alexion-pharmaceuticals-inc-nasdaqgsalxn-technicals-in-the-spotlight/561451/&cid=52779696485382&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNHAkwCr6WWkPfYBksLlAwj_-4LdzA""",18,"""Financial Newsweek"""
"""Nov 23, 2017""","""Recent Institutional Activity: Alexion Pharmaceuticals, Inc. (ALXN), Abraxas\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://financialqz.com/2017/11/23/recent-institutional-activity-alexion-pharmaceuticals-inc-alxn-abraxas-petroleum-corporation-axas/&cid=0&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNHKSJn3QPdbvnPczORcLjCHzmYuQQ""",19,"""Market Movers"""
"""Nov 17, 2017""","""Revenue Approximations Analysis: Abercrombie & Fitch Co. (ANF), Alexion\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/17/revenue-approximations-analysis-abercrombie-fitch-co-anf-alexion-pharmaceuticals-inc-alxn/&cid=52779679936760&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNHSMGj_1Ik0UI6OHS6zyNkGaxiHTA""",20,"""StockNewsJournal"""
"""Nov 22, 2017""","""Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Stake Increased by Meag Munich\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/22/meag-munich-ergo-kapitalanlagegesellschaft-mbh-buys-14956-shares-of-alexion-pharmaceuticals-inc-alxn.html&cid=52779686513267&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNGKgvP3DGlYvaJqwm8-pP-hApybnw""",Not Reachable,"""The Ledger Gazette"""
"""10 hours ago""","""Sell-Side Sees Upside & Positive Growth in Alexion Pharmaceuticals, Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://aikenadvocate.com/sell-side-sees-upside-positive-growth-in-alexion-pharmaceuticals-inc-nasdaqalxn/650364/&cid=52779696950291&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNEhtAMumGf3EKSu0xPxhJa4aFZk1Q""",21,"""Aiken Advocate"""
"""Nov 9, 2017""","""Why Investors remained confident on Alexion Pharmaceuticals, Inc. (ALXN), Bank\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stocknewsjournal.com/2017/11/09/why-investors-remained-confident-on-alexion-pharmaceuticals-inc-alxn-bank-of-the-ozarks-ozrk/&cid=52779668159323&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNEuqldQBjbQ6ZDsXMGThbMqou6OvQ""",22,"""StockNewsJournal"""
"""Nov 27, 2017""","""Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN), The Goldman Sachs Group, Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/27/alexion-pharmaceuticals-inc-nasdaq-alxn-the-goldman-sachs-group-inc-nyse-gs-british-american-tobacco-p-l-c-nyse-bti-armstrong-world-industries-inc-nyse-awi-notable-bulls-an/&cid=52779689578497&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNECDXEc1lBje_LO1hPQcAb1P7GIDg""",Not Reachable,"""Stocks In The News (press release)"""
"""Nov 28, 2017""","""Active Mover: Alexion Pharmaceuticals Inc (NASDAQ:\u00a0ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://alphabetastock.com/active-mover-alexion-pharmaceuticals-inc-nasdaq-alxn/&cid=52779695040922&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNE_ohdpW5zHK7QLT4MDC-cTeDw6og""",23,"""Alpha Beta Stock"""
"""Nov 14, 2017""","""How technical signals have emerged? \u2013 Sage Therapeutics, Inc. (SAGE), Alexion\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://postanalyst.com/2017/11/14/how-technical-signals-have-emerged-sage-therapeutics-inc-sage-alexion-pharmaceuticals-inc-alxn/&cid=52779672729451&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNG526fna5TErLvkMCog2VX-lKMLMA""",24,"""Post Analyst"""
"""Nov 27, 2017""","""Banque Pictet & Cie SA Sells 10948 Shares of Alexion Pharmaceuticals, Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.truebluetribune.com/2017/11/27/alexion-pharmaceuticals-inc-alxn-shares-sold-by-banque-pictet-cie-sa.html&cid=52779693077347&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNE_hlgmQ5ViiuOF0pX4JJHjvSdpXw""",Not Reachable,"""TrueBlueTribune"""
"""Nov 28, 2017""","""Biotech Pullback Makes Bargains Out Of Alexion, Flexion, Clovis, Tesaro And\u00a0Incyte""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.forbes.com/sites/kenkam/2017/11/28/biotech-pullback-makes-bargains-out-of-alexion-flexion-clovis-tesaro-and-incyte/&cid=0&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNGyW1Ohdb3nlIaO6qU1p04NtIV-Eg""",25,"""Forbes"""
"""16 hours ago""","""Is Alexion Pharmaceuticals Inc. (AXP.DE)'s Price Index Saturation Running on\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stockdailyreview.com/is-alexion-pharmaceuticals-inc-axp-des-price-index-saturation-running-on-empty/&cid=52779696303481&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNENpav0yLH1YqWLkEAYflAGZ1nbPw""",26,"""Stock Daily Review"""
"""Nov 16, 2017""","""USA Financial Portformulas Corp Purchases Shares of 25886 Alexion\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/16/usa-financial-portformulas-corp-invests-3-63-million-in-alexion-pharmaceuticals-inc-alxn.html&cid=52779678460203&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNFXrxfU_c9hJUG2oraRe2od42oFfw""",Not Reachable,"""The Ledger Gazette"""
"""Nov 23, 2017""","""Notable Eye Catching Stocks: Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/23/notable-eye-catching-stocks-alexion-pharmaceuticals-inc-nasdaq-alxn-ssr-mining-inc-nasdaq-ssrm-eog-resources-inc-nyse-eog-the-hartford-financial-services-group-inc-nyse-hig/&cid=0&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNERNv965k55mHPNKZgyVTfbGq7Tjg""",Not Reachable,"""Stocks In The News (press release)"""
"""Nov 3, 2017""","""Alexion Pharma (ALXN) Announces New Interim Survival Data on LAL-D Treated\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.streetinsider.com/Corporate%2BNews/Alexion%2BPharma%2B%2528ALXN%2529%2BAnnounces%2BNew%2BInterim%2BSurvival%2BData%2Bon%2BLAL-D%2BTreated%2Bwith%2BKanuma%2B%2528sebelipase%2Balfa%2529/13461415.html&cid=52779661614493&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNEy92v2lvlVoWoolwTRre0iz2SW-Q""",Not Reachable,"""StreetInsider.com"""
"""Nov 21, 2017""","""Traders Brace for Comeback of Volatility: Chico's FAS, Inc. (CHS), Alexion\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://postanalyst.com/2017/11/21/traders-brace-for-comeback-of-volatility-chicos-fas-inc-chs-alexion-pharmaceuticals-inc-alxn/&cid=52779684943403&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNElbOAwrjuoRyymfG8JMMwSswAvtw""",27,"""Post Analyst"""
"""Nov 25, 2017""","""Stock Volatility Risk Alert: Alexion Pharmaceuticals Inc Stock Volatility Hits\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://news.cmlviz.com/2017/11/25/stock-volatility-risk-alert-alexion-pharmaceuticals-inc-stock-volatility-hits-a-notable-high.html&cid=52779690303972&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNEnocxYxsCbaIMT5sqhdKlW25WPLA""",28,"""CML News"""
"""Nov 25, 2017""","""Risk Malaise Alert in Option Market: Alexion Pharmaceuticals Inc Implied Price\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://news.cmlviz.com/2017/11/25/risk-malaise-alert-in-option-market-alexion-pharmaceuticals-inc-implied-price-swing-hits-a-reduced-level.html&cid=52779689240783&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNFT8Ns_DCUgwuxckR4jr3Nj1ES30A""",29,"""CML News"""
"""Nov 27, 2017""","""Analysts said to Buy Healthcare Stock: Alexion Pharmaceuticals, Inc.\u00a0(ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.streetobserver.com/2017/11/27/analysts-said-to-buy-healthcare-stock-alexion-pharmaceuticals-inc-alxn/&cid=52779693115516&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNE1v7TDSdiwiD0_a1E-zHFPDIu1IA""",30,"""Street Observer (press release)"""
"""13 hours ago""","""bioAffinity Technologies Welcomes New Board\u00a0Members""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://globenewswire.com/news-release/2017/11/29/1210508/0/en/bioAffinity-Technologies-Welcomes-New-Board-Members.html&cid=52779696564936&ei=q5wfWonuEsTg2Aa3y6-YAw&usg=AFQjCNGsAtbZO_JWlg0t75u1yKvECJBFrw""",31,"""GlobeNewswire (press release)"""
"""Nov 28, 2017""","""Alexion Pharmaceuticals, Inc. (ALXN) is at $107.75 per share and Cascadian\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stocksgallery.com/2017/11/28/alexion-pharmaceuticals-inc-alxn-is-at-107-75-per-share-and-cascadian-therapeutics-inc-casc-is-listed-at-4-24/&cid=0&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNHfBBJzjQNGBWFV7FtyL9zkErUjvQ""",32,"""Stocks Gallery"""
"""10 hours ago""","""Hot Stock's Highlights: Alexion Pharmaceuticals, Inc. (NASDAQ:\u00a0ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.wallstreetnews24.com/2017/11/29/hot-stocks-highlights-alexion-pharmaceuticals-inc-nasdaq-alxn/&cid=52779696555537&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNHQeStHsvPpvUVKFBYDQQl8uE9g4Q""",33,"""The Investor Guide"""
"""Nov 3, 2017""","""Comparing Alexion Pharmaceuticals, Inc. (ALXN) and Vertex Pharmaceuticals\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stocknewsgazette.com/2017/11/03/comparing-alexion-pharmaceuticals-inc-alxn-and-vertex-pharmaceuticals-incorporated-vrtx/&cid=52779659377127&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNF1QGvipv1l_S7D-D5DqhqIF4Dbeg""",34,"""StockNewsGazette"""
"""Nov 28, 2017""","""RSI Alert: Alexion Pharmaceuticals, Inc. (NASDAQ:\u00a0ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.hotstockspoint.com/2017/11/rsi-alert-alexion-pharmaceuticals-inc-nasdaq-alxn/&cid=52779693887277&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNG39fnb4Ob92tiOM2X1e6La0-ITZA""",35,"""Hot Stocks Point"""
"""Nov 14, 2017""","""Worth Watching Stocks on the Run: Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/14/worth-watching-stocks-on-the-run-alexion-pharmaceuticals-inc-nasdaq-alxn-bofi-holding-inc-nasdaq-bofi-cott-corporation-nyse-cot-evolent-health-inc-nyse-evh/&cid=52779668715992&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNF7bxMMGZl-vDEhVIdnACsoGOc3JA""",Not Reachable,"""Stocks In The News (press release)"""
"""Nov 21, 2017""","""The Bottom Line on NGL Energy Partners LP (NGL), Alexion Pharmaceuticals, Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.allstocknews.com/2017/11/21/the-bottom-line-on-ngl-energy-partners-lp-ngl-alexion-pharmaceuticals-inc-alxn/&cid=52779685110296&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNGdMwoJw84nz9cJVrTGMHbc2dt7Jw""",36,"""AllStockNews"""
"""Nov 21, 2017""","""Alexion Pharmaceuticals, Inc. (ALXN) has current market capitalization of $24\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://standardoracle.com/2017/11/21/alexion-pharmaceuticals-inc-alxn-has-current-market-capitalization-of-24-19-billion/&cid=0&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNFku-3PSrmqoXDuLFpNXu7iHsVmvg""",37,"""StandardOracle"""
"""Nov 22, 2017""","""Flickering Stocks:: Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN), First\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/22/alexion-pharmaceuticals-inc-nasdaq-alxn-first-midwest-bancorp-inc-nasdaq-fmbi-the-charles-schwab-corporation-nyse-schw-tailored-brands-inc-nyse-tlrd-74658/&cid=52779679780037&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNFqVjI3pclNS4Uu88uBIkeHQDMpIA""",Not Reachable,"""Stocks In The News (press release)"""
"""Nov 16, 2017""","""A Technical Look At 2 Stocks: Noble Energy, Inc. (NBL), Alexion\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://postanalyst.com/2017/11/16/a-technical-look-at-2-stocks-noble-energy-inc-nbl-alexion-pharmaceuticals-inc-alxn/&cid=52779673527958&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNFG8WIx0dR-FJ42vO11y-OHnq5REg""",38,"""Post Analyst"""
"""Nov 27, 2017""","""How to Trade these Stock After an unavoidable Selloff: Adobe Systems\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/27/how-to-trade-these-stock-after-an-unavoidable-selloff-adobe-systems-incorporated-adbe-alexion-pharmaceuticals-inc-alxn/&cid=52779690169687&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNEFMH2vTWDnymgcFvVp0M9xZ_1Ocw""",39,"""StockNewsJournal"""
"""Nov 9, 2017""","""Alexion Employees Volunteer Together to Enhance Their Local Communities during\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.businesswire.com/news/home/20171109005434/en/Alexion-Employees-Volunteer-Enhance-Local-Communities-Annual&cid=52779668750323&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNF3nwBm34CKUicQzhAd7aklMiebSA""",40,"""Business Wire (press release)"""
"""Nov 28, 2017""","""Swings under Technical Examination: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.investingbizz.com/2017/11/swings-under-technical-examination-alexion-pharmaceuticals-inc-nasdaqalxn-endeavour-silver-corp-nyseexk/&cid=52779692115699&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNGe_Z5-7eJ2XXibK_asXq9xKNo5Ug""",41,"""Investing News Update"""
"""Nov 24, 2017""","""Turquoise Hill Resources Ltd., (NYSE: TRQ), Alexion Pharmaceuticals, Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/24/turquoise-hill-resources-ltd-nyse-trq-alexion-pharmaceuticals-inc-nasdaq-alxn-ssr-mining-inc-nasdaq-ssrm-cubesmart-nyse-cube-stocks-trend-analysis-report/&cid=52779689078405&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNEOm97vo1lV--b-TQY6mQwVxrUJdA""",Not Reachable,"""Stocks In The News (press release)"""
"""Nov 27, 2017""","""Hot Stock in the Spotlight \u2013 Alexion Pharmaceuticals, Inc., (NASDAQ:\u00a0ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stockznews.com/2017/11/27/hot-stock-in-the-spotlight-alexion-pharmaceuticals-inc-nasdaq-alxn/&cid=52779692780989&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNFr3WtY4FqGQjH8QPBfWMJTkO_8Hw""",Not Reachable,"""Daily Hot Picks"""
"""Nov 27, 2017""","""Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.gurufocus.com/news/601832/sphera-funds-management-ltd-buys-cellcom-israel-allergan-plc-teva-pharmaceutical-industries-sells-novartis-ag-bristolmyers-squibb-company-alexion-pharmaceuticals-inc&cid=0&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNEAxIDSJuQkRsEjpE5UR1w1NQgnVw""",42,"""GuruFocus.com"""
"""Nov 8, 2017""","""Reviewing BioMarin Pharmaceutical (NASDAQ:BMRN) & Alexion Pharmaceuticals\u00a0(ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/08/financial-analysis-biomarin-pharmaceutical-bmrn-vs-alexion-pharmaceuticals-alxn.html&cid=52779664677443&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNE19PDGUACjdhiyc_9d1YfDzH071w""",Not Reachable,"""The Ledger Gazette"""
"""Nov 27, 2017""","""Alexion Pharmaceuticals, Inc. (ALXN) is at $108.61 per share and Intuitive\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stocksgallery.com/2017/11/27/alexion-pharmaceuticals-inc-alxn-is-at-108-61-per-share-and-intuitive-surgical-inc-isrg-is-listed-at-398-15/&cid=52779692504044&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNFh7gCswqKrVhUt5fCRwEz6TzxgfQ""",43,"""Stocks Gallery"""
"""Nov 24, 2017""","""What Do You Say about Oversold stock: Alexion Pharmaceuticals, Inc.\u00a0(ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.analystsbuzz.com/2017/11/24/what-do-you-say-about-oversold-stock-alexion-pharmaceuticals-inc-alxn/&cid=52779688508954&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNHijS-RPnyQYB5Iz-Z1Eml6BZCujA""",44,"""Voice Of Analysts"""
"""Nov 21, 2017""","""Comprehensive Stock Analysis: Alexion Pharmaceuticals Inc (NASDAQ:\u00a0ALXN)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://alphabetastock.com/comprehensive-stock-analysis-alexion-pharmaceuticals-inc-nasdaq-alxn/&cid=52779685073784&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNFWrHXJCkauXmvkpK6skHxjIqdbkQ""",45,"""Alpha Beta Stock"""
"""Nov 15, 2017""","""Two Stocks You May Need To Reconsider: Alexion Pharmaceuticals, Inc. (ALXN\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.allstocknews.com/2017/11/15/two-stocks-you-may-need-to-reconsider-alexion-pharmaceuticals-inc-alxn-collegium-pharmaceutical-inc-coll/&cid=52779674308480&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNGF7Zz_Xzp6E0zgcawMMKYMVCLwMA""",46,"""AllStockNews"""
"""Nov 28, 2017""","""Alexion Pharmaceuticals, Inc. (ALXN) \u2013 Track the Possession of Insider\u00a0Investors""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.wallstreetinvestorplace.com/2017/11/alexion-pharmaceuticals-inc-alxn-track-the-possession-of-insider-investors/&cid=52779695262757&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNHlx_TAbQ0JdKwcTLDyDHpb4dLRhA""",47,"""Wallstreet Investorplace"""
"""Nov 21, 2017""","""Alexion Pharmaceuticals, Inc. (ALXN) is at $108.49 per share and Concert\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stocksgallery.com/2017/11/21/alexion-pharmaceuticals-inc-alxn-is-at-108-49-per-share-and-concert-pharmaceuticals-inc-cnce-is-listed-at-21-25/&cid=52779684972858&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNGTBzFnc64vIvXZPhgJlTYEM6SHoA""",48,"""Stocks Gallery"""
"""Nov 28, 2017""","""Head to Head Contrast: Alexion Pharmaceuticals (ALXN) & Mirna Therapeutics\u00a0(SYBX)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://weekherald.com/2017/11/28/head-to-head-contrast-alexion-pharmaceuticals-alxn-mirna-therapeutics-sybx.html&cid=52779694261857&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNH9HdBLZ5QNw-8HLrFmvpgf73ODcw""",Not Reachable,"""Week Herald"""
"""Nov 24, 2017""","""Point72 Asset Management Lp Decreased Alexion Pharmaceuticals Inc (NASDAQ:ALXN\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://finnewsdaily.com/point72-asset-management-lp-decreased-alexion-pharmaceuticals-inc-nasdaqalxn-stake-by-19-61-million/&cid=0&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNGIdiSmisJeWEKxxuNGg8cKsR3dXg""",49,"""Finance News Daily"""
"""Nov 25, 2017""","""Alexion Pharmaceuticals (ALXN) Shares Declined While Sands Capital Management\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://bzweekly.com/alexion-pharmaceuticals-alxn-shares-declined-while-sands-capital-management-lifted-by-134-36-million-its-holding-as-nxp-semiconductors-nv-nxpi-market-valuation-rose-shareholder-havens-advisors/&cid=52779686762863&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNFNpgAM1lW5IA2TIgfDhIOGvKGhgg""",50,"""BZ Weekly"""
"""Nov 28, 2017""","""Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN)'s Piotrioski's F-Score in\u00a0Focus""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://rockvilleregister.com/alexion-pharmaceuticals-inc-nasdaqgsalxns-piotrioskis-f-score-in-focus/553049/&cid=52779696948429&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNGA_APJW2EbQuU5p9Dvxli-bnMIUQ""",51,"""Rockville Register"""
"""Nov 28, 2017""","""Volume: A Tool to Project Future Performance \u2013 Alexion Pharmaceuticals, Inc\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://stockznews.com/2017/11/28/volume-a-tool-to-project-future-performance-alexion-pharmaceuticals-inc-nasdaq-alxn/&cid=52779695058658&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNEQCem-BBkg4VB7emxIFw8VZ6kvLg""",52,"""Daily Hot Picks"""
"""Nov 24, 2017""","""Alexion Pharmaceuticals, Inc. (ALXN) stock remained among Quarterly Losers\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.streetobserver.com/2017/11/24/alexion-pharmaceuticals-inc-alxn-stock-remained-among-quarterly-losers-with-decline-of-21-90/&cid=52779689296366&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNE1inGVY5rvwa3eO5XgJUkskSqPhA""",53,"""Street Observer (press release)"""
"""15 hours ago""","""The Coca-Cola Company (KO) Stocks with Considerable Review with Margins And\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.investingbizz.com/2017/11/the-coca-cola-company-ko-stocks-with-considerable-review-with-margins-and-returns-alexion-pharmaceuticals-inc-alxn/&cid=52779696274915&ei=dZ0fWomGC8Ox2AbN24OgCg&usg=AFQjCNETbzGlpfJ_dKzl7G_Ex4ByExMeJg""",54,"""Investing News Update"""
"""Oct 24, 2017""","""Alexion Pharmaceuticals says U.S. FDA approves Soliris for treatment of patients with\u00a0GMG""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3692264&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNGUyc2YN5-Bdo8wXYM8e28msnkiOQ""",Not Reachable,"""Reuters Key Development"""
"""Sep 27, 2017""","""Canada's PMPRB hearing panel issues decision in Soliris\u00a0case""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3678926&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNFdd4ipjFpBCF86C32laCy2YqgySg""",Not Reachable,"""Reuters Key Development"""
"""Sep 13, 2017""","""BRIEF-Alexion announces interim analysis from phase 3 open-label extension study of\u00a0Soliris""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3671982&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNF6ko81KIt2n4B3LCbOiWM-kDN_cw""",Not Reachable,"""Reuters Key Development"""
"""Sep 13, 2017""","""Interim analysis from phase 3 open-label extension study of\u00a0Soliris""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3671978&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNHYrtc1y4MxdZNYi0qi2_IR7LHinA""",Not Reachable,"""Reuters Key Development"""
"""Sep 12, 2017""","""Alexion to reduce 20 pct of its global\u00a0workforce""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3670992&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNHnrpFBCGgkc9JZ-dhpdlkVzLkncA""",Not Reachable,"""Reuters Key Development"""
"""Aug 21, 2017""","""European Commission grants new indication for\u00a0Soliris""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3657116&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNFkWSVX2Ms1w2ZUJ4xGyqUjJB-ZKQ""",Not Reachable,"""Reuters Key Development"""
"""Aug 15, 2017""","""Alexion receives three U.S. Patents for Soliris (eculizumab), extending patent protection into\u00a02027""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3653931&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNF47me8F6y3OZ2dmQzIT_HAfmIOAQ""",Not Reachable,"""Reuters Key Development"""
"""Jul 27, 2017""","""Blueprint Medicines to evaluate advance disease discovery program\u00a0opportunities""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3637219&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNEp9LOH7Zk3PW1ZgbpBmVnPpShMbQ""",Not Reachable,"""Reuters Key Development"""
"""Jun 23, 2017""","""Alexion receives positive CHMP opinion for Soliris in the\u00a0EU""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3617097&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNHz2tVFEeeJWcQahh2LnQ_7E_EuFA""",Not Reachable,"""Reuters Key Development"""
"""Jun 13, 2017""","""Alexion Pharmaceuticals in connection with appointment as CFO, Paul Clancy will receive stock options valued about $1.2\u00a0million""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3611343&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNHOJDY9zaHBTcDP4u3laWs6kLzIJg""",Not Reachable,"""Reuters Key Development"""
"""Jun 13, 2017""","""Alexion Pharmaceuticals names Paul Clancy as\u00a0CFO""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3611323&ei=2p0fWunsCNj82AbW_JqIBw&usg=AFQjCNEb9OkPnA7krF5giyreSAWjIMJk1Q""",Not Reachable,"""Reuters Key Development"""
"""May 23, 2017""","""Alexion Pharmaceuticals says CFO will\u00a0resign""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3599341&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNE_vXcDzQ1k3m4E5aOZ6MFma--clg""",Not Reachable,"""Reuters Key Development"""
"""Mar 27, 2017""","""Alexion appoints Ludwig Hantson as chief executive\u00a0officer""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3555704&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNH7hl-95rIlPl7paHFZy-yCIrICsA""",Not Reachable,"""Reuters Key Development"""
"""Mar 16, 2017""","""Arbutus licenses LNP delivery technology to\u00a0Alexion""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3549369&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNFR9540akGKP9W_woPYkWV5Xx3AHg""",Not Reachable,"""Reuters Key Development"""
"""Mar 13, 2017""","""Alexion Pharma says initiated companywide\u00a0restructuring""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3546030&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNGBZ6F31E2mdy4DTEQT0EBsfrdFmg""",Not Reachable,"""Reuters Key Development"""
"""Mar 8, 2017""","""FDA accepts sBLA filing of soliris as potential treatment for patients with refractory generalized myasthenia\u00a0gravis""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3543029&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNHRrSBVP2wylksWAQnTcXynD8JHKg""",Not Reachable,"""Reuters Key Development"""
"""Feb 16, 2017""","""Alexion interim CEO says looking for opportunities in M&A\u00a0front""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3529648&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNHHhD-GD3GdiU8oYLcRKli_BbaQnw""",Not Reachable,"""Reuters Key Development"""
"""Feb 16, 2017""","""Alexion Pharmaceuticals posts Q4 adj. earnings\u00a0$1.26/shr""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3529417&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNEy0Q_IcfN9nYZfXr-DpRBUM-uZwQ""",Not Reachable,"""Reuters Key Development"""
"""Jan 9, 2017""","""Alexion interim CEO says company is not up for sale -\u00a0conf""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3505928&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNGaSGj1Nu8bw_0MXHIGXpaLUnD7FA""",Not Reachable,"""Reuters Key Development"""
"""Jan 9, 2017""","""Alexion submits U.S. and EU applications seeking approval of Soliris as a treatment for patients with refractory generalized myasthenia\u00a0gravis""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3505685&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNGi0NS8477xM-PYRd1Za6BsBRlfdQ""",Not Reachable,"""Reuters Key Development"""
"""Jan 6, 2017""","""FDA grants orphan drug designation to\u00a0ALXN1210""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3505001&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNHhvZ1mF6Nj63Ebp9TqMi5FYN2gAQ""",Not Reachable,"""Reuters Key Development"""
"""Jan 4, 2017""","""Alexion Pharmaceuticals files form 10-q for Q3\u00a02016""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3504147&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNHeZsT9OPL8PGDidrP3zSBEzuLu_w""",Not Reachable,"""Reuters Key Development"""
"""Dec 12, 2016""","""Alexion Pharmaceuticals names David Brennan interim\u00a0CEO""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3493511&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNFBTuqs9AF3oRhiCEiyEVhZgKo4QA""",Not Reachable,"""Reuters Key Development"""
"""Nov 14, 2016""","""Paulson & Co cuts share stake in Alexion Pharmaceuticals, Johnson &\u00a0Johnson""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3478215&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNHDVa4ZqPvOJnMHiOHSfNZk3p2Knw""",Not Reachable,"""Reuters Key Development"""
"""Nov 9, 2016""","""Alexion Pharmaceuticals files for non-timely\u00a010-Q""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3474009&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNF0jFPaOLA2yPkW7HWkwl67esgFDA""",Not Reachable,"""Reuters Key Development"""
"""Oct 27, 2016""","""Alexion Pharmaceuticals posts Q3 non-gaap EPS of\u00a0$1.23""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3462853&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNHhe3CMsxyqM8SWNTJUMR-eNLHxPg""",Not Reachable,"""Reuters Key Development"""
"""Aug 29, 2016""","""Alexion gets orphan drug designation for\u00a0ALXN1007""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3434096&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNGRN60NuDUa6i7H20yxiOP_A5lnfg""",Not Reachable,"""Reuters Key Development"""
"""Aug 8, 2016""","""Alexion Pharmaceuticals-FDA recently completed routine current good manufacturing practice inspection of Co's Smithfield, Rhode Island Manufacturing\u00a0Facility""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3421556&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNG9Pjg9brypY3YJKD8gm4fJ4o1adg""",Not Reachable,"""Reuters Key Development"""
"""Jul 28, 2016""","""Alexion reports Q2 non-gaap EPS\u00a0$1.13""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3413781&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNGNGlxJdDlnQrfOvhj6fJU9gR-IfQ""",Not Reachable,"""Reuters Key Development"""
"""Jun 10, 2016""","""Alexion Pharmaceuticals announces data from phase 1/2 study of\u00a0ALXN1210""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3389536&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNG6uPjXTCa3YevUxuPJ2x3rLjjbCQ""",Not Reachable,"""Reuters Key Development"""
"""Jun 6, 2016""","""Alexion announces topline results from Phase 3 regain study of\u00a0eculizumab""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3387322&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNEfQl_hX_F9W0GteP2XFsmZ7_hcDQ""",Not Reachable,"""Reuters Key Development"""
"""Jun 1, 2016""","""Alexion Pharmaceuticals says EC grants orphan drug designation to\u00a0ALXN1210""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3385467&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNEsPeGsRDMwg_ziI_yfOSiNQfas7w""",Not Reachable,"""Reuters Key Development"""
"""Feb 3, 2016""","""Alexion Pharmaceuticals Inc gives FY 2016\u00a0guidance""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FALXN.O%2Fkey-developments%2Farticle%2F3328116&ei=fp4fWpmAJ8TcjAHz34eADA&usg=AFQjCNE0AqqmUDz9_TDZkDuLmmSxy23vFw""",Not Reachable,"""Reuters Key Development"""
